New Delhi: Adar Poonawalla, Executive Director of the Serum Institute of India (SII), reported that the COVID-19 vaccination campaign in India is likely to start in January 2021, as his company hoped to obtain emergency use authorization from the panel for the end of the month.
Speaking at The Economic Times Global Business Summit on Saturday, Poonawalla said that he hoped everyone in India would be vaccinated before October 2021 that would pave the way for a return to normal life.
“At the end of the month, we could get an emergency license, but the actual license for wider use could come at a later date. But we are sure that if the regulators approve it, India vaccination campaign it can start in January 2021, ”said Adar Poonawalla.
“Once 20% of India receives the coronavirus vaccine, we can see the confidence and feelings return, and by September-October next year there will be enough vaccines for everyone and normal life can return,” he said.
Previously, a committee of experts from the Central Drug Control Organization (CDSCO) sought additional safety and efficacy data for IBS and Bharat Biotech coronavirus vaccine candidates after deliberating on their applications to obtain authorization for use of emergency for injections.
Adar Poonawalla has said that the government wants to purchase 300-400 million doses by July 2021 and Serum is preparing to make enough coronavirus vaccines for the government and private markets.
As India prepares for the vaccination campaign, the government said a total of 100 people are expected to receive the anti-CVOID-19 injections at each site per day.
Interim results from Oxford COVID-19 vaccine trials, published in The Lancet, show that the vaccine protects against symptomatic disease in 70 percent of cases, with a vaccine efficacy of 62 percent for recipients. two full doses and 90 percent. percent in those who received half, and then a full dose.
(With contributions from the agency)
On live Tv